Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2013-03-11 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAUVIAN (34410), Herault
SELURL PHARMACIE LA FONT VIVE : revenue, balance sheet and financial ratios
SELURL PHARMACIE LA FONT VIVE is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAUVIAN (34410),
this company of category PME
shows in 2022 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE LA FONT VIVE (SIREN 791709413)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
2 566 830 €
N/C
N/C
N/C
N/C
1 900 390 €
1 858 648 €
1 844 410 €
Net income
187 602 €
168 197 €
212 081 €
199 507 €
130 887 €
134 557 €
116 502 €
101 214 €
71 915 €
104 381 €
EBITDA
N/C
N/C
342 311 €
N/C
N/C
N/C
N/C
195 065 €
140 283 €
170 278 €
Net margin
N/C
N/C
8.3%
N/C
N/C
N/C
N/C
5.3%
3.9%
5.7%
Revenue and income statement
In 2024, SELURL PHARMACIE LA FONT VIVE generates positive net income of 188 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 104 k€ -> 188 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
187 602 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
50.92%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
57.741%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE LA FONT VIVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
430.98
322.181
279.159
217.571
162.306
131.815
125.221
91.207
67.806
50.92
Financial autonomy
16.11
18.742
22.917
28.672
33.925
37.617
39.769
45.896
53.758
57.741
Repayment capacity
15.926
16.43
11.427
None
None
None
None
4.475
None
None
Cash flow / Revenue
5.095%
4.422%
6.69%
None%
None%
None%
None%
10.432%
None%
None%
Sector positioning
Debt ratio
50.922024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-8 pts over 3 years
In 2024, the debt ratio of SELURL PHARMACIE LA FONT ... (50.92) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
57.74%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+12 pts over 3 years
In 2024, the financial autonomy of SELURL PHARMACIE LA FONT ... (57.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.47 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELURL PHARMACIE LA FONT ... (4.47) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 297.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
297.66
Liquidity indicators evolution SELURL PHARMACIE LA FONT VIVE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
145.694
119.039
199.29
276.063
242.885
241.19
283.762
275.517
339.188
297.66
Interest coverage
16.388
28.55
26.658
None
None
None
None
3.324
None
None
Sector positioning
Liquidity ratio
297.662024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of SELURL PHARMACIE LA FONT ... (297.66) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.32x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Good
In 2022, the interest coverage of SELURL PHARMACIE LA FONT ... (3.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE LA FONT VIVE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
32 019 €
-20 073 €
101 367 €
0 €
0 €
0 €
0 €
168 666 €
0 €
0 €
Inventory turnover (days)
31
27
28
0
0
0
0
27
0
0
Customer payment term (days)
7
10
7
0
0
0
0
6
0
0
Supplier payment term (days)
32
54
50
0
0
0
0
53
0
0
Positioning of SELURL PHARMACIE LA FONT VIVE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELURL PHARMACIE LA FONT VIVE is estimated at
2 619 062 €
(range 1 823 873€ - 3 918 267€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1823k€2619k€3918k€
2 619 062 €Range: 1 823 873€ - 3 918 267€
NAF 5 année 2024
Valuation method used
Net Income Multiple
187 602 €
×
14.0x
=2 619 063 €
Range: 1 823 874€ - 3 918 268€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE LA FONT VIVE with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE LA FONT VIVE
What is the revenue of SELURL PHARMACIE LA FONT VIVE ?
The revenue of SELURL PHARMACIE LA FONT VIVE in 2022 is 2.6 M€.
Is SELURL PHARMACIE LA FONT VIVE profitable?
Yes, SELURL PHARMACIE LA FONT VIVE generated a net profit of 188 k€ in 2024.
Where is the headquarters of SELURL PHARMACIE LA FONT VIVE ?
The headquarters of SELURL PHARMACIE LA FONT VIVE is located in SAUVIAN (34410), in the department Herault.
Where to find the tax return of SELURL PHARMACIE LA FONT VIVE ?
The tax return of SELURL PHARMACIE LA FONT VIVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE LA FONT VIVE operate?
SELURL PHARMACIE LA FONT VIVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart